DAVID EMERSON JORDEN
CIK 1313516 · CEO/CFO · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
162
Lifetime Open-Market Net
$1.59M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLx Pharma Inc. (PLXP) Delisted | Acting Chief Financial Officer | 151,913 | $0.09 | $13.2K | $225.0K | 2 | 2017-06-16 |
| Acer Therapeutics Inc. (OPXAW) Delisted | Acting Chief Financial Officer | 293,456 | — | — | $155.3K | 24 | 2013-09-26 |
| ConnectOne Bancorp, Inc. (CNBC) Delisted | Director | 5,765,000 | — | — | $29.2K | 1 | 2011-03-09 |
| Nuo Therapeutics, Inc. (GTF) Delisted | Director | 5,402,858 | — | — | $1.18M | 82 | 2011-01-26 |
Recent Filings · Page 11 of 17
162 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-10-26 | Nuo Therapeutics, Inc. (GTF) Delisted | Buy (P) | +35,000 | $15.8K | EDGAR |
| 2010-10-25 | Nuo Therapeutics, Inc. (GTF) Delisted | Buy (P) | +25,848 | $11.9K | EDGAR |
| 2010-10-22 | Nuo Therapeutics, Inc. (GTF) Delisted | Buy (P) | +32,223 | $14.8K | EDGAR |
| 2010-10-21 | Nuo Therapeutics, Inc. (GTF) Delisted | Other (J) | +4,315 | $0 | EDGAR |
| 2010-10-12 | Nuo Therapeutics, Inc. (GTF) Delisted | Buy (P) | +112,677 | $59.7K | EDGAR |
| 2010-07-19 | Nuo Therapeutics, Inc. (GTF) Delisted | Other (J) | +3,837 | $0 | EDGAR |
| 2010-07-15 | Nuo Therapeutics, Inc. (GTF) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-06-15 | Acer Therapeutics Inc. (OPXAW) Delisted | Buy (P) | +28,091 | $45.5K | EDGAR |
| 2010-06-10 | Acer Therapeutics Inc. (OPXAW) Delisted | Conv (C) | +211,909 | $106.0K | EDGAR |
| 2010-06-10 | Nuo Therapeutics, Inc. (GTF) Delisted | Buy (P) | +23,100 | $11.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.